Dec 6 (Reuters) - AstraZeneca PLC : * European Commission approves intranasal four-strain influenza vaccine Fluenz Tetra * Follows a positive opinion from
By Cristina Tov : To enhance the safety and efficacy profile of its probable future blockbuster cancer drug, "Palbociclib," Pfizer ( PFE ) collaborated with GlaxoSmithKline ( GSK ) . The company will evaluate Palbociclib in combination with GlaxoSmithKline's MEK inhibitor "Mekinist," also known as
per year from the following tax sheltered portfolio: T att-$35,000, Vz - Verizon-$35,000, Ed Con Ed- $35,000, Azn Astra Zeneca-$35,000, MO Altria-$35,000 O Reality prtnrs$35,000, NYCB , $35,000 Pimix Pimco income $100
By Marsha Robe : Acadia Pharmaceuticals ( ACAD ) announced the results of the phase III trial of its drug "Pimavanserin" in treating patients with Parkinson's disease psychosis, or PDP. In this pivotal study, Pimavanserin achieved both the endpoints demonstrating significant reduction in psychosis
Wall Street Breakfast Editors submit: Top Stories EU fines banks €1.71B for rate-rigging. The EU Commission has fined a group of leading multinational banks €1.71B for rigging inter-bank interest rates in what is the largest antitrust penalty that the commission has ever levied. The banks being ...
"Novartis now joins Sanofi, Medimmune ( AstraZeneca ), and Hikma, which have entered into long-term deals," Cantor's Jeremy Feffer says, reiterating a Buy rating on shares
NEW YORK, Dec 3 (Reuters) - A U.S. federal judge has awarded AstraZeneca Plc $76 million in damages from generic drug manufacturer Apotex for infringing upon patents for AstraZeneca 's blockbuster heartburn drug, Prilosec, between 2003 and 2007.
By Looking For Diogenes : When investing in real estate, the mantra is: "Location! Location! Location!" However, when investing in the biotech arena the proper mantra is: "Timing! Timing and Good Science!" What better example for investing in a biotech based on this criterion -- one needs to look
By Futuristics : On October 29, the FDA dashed Amarin's ( AMRN ) hopes for its fish-oil-based drug, Vascepa, for treating patients suffering with high triglyceride, or TG, levels ( =499 mg/dL). TG is a kind of fat found in blood lipid that helps transfer blood glucose from the liver to other body
witness their share prices sky rocket following the approval of a drug or a positive review. The British drug maker AstraZeneca PLC ( AZN ) recently received a positive opinion on the approval of its Xigduo (dapagliflozin and metformin hydrochloride